| 0 (0%) | 02-21 12:57 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 7.83  |
1-year : | 8.7 |
| Resists | First : | 6.7 |
Second : | 7.44 |
| Pivot price | 5.91 |
|||
| Supports | First : | 5.51 | Second : | 4.58 |
| MAs | MA(5) : | 6.04 |
MA(20) : | 5.87 |
| MA(100) : | 6.53 |
MA(250) : | 6.32 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 71.6 |
D(3) : | 68.3 |
| RSI | RSI(14): 48.4 |
|||
| 52-week | High : | 8.68 | Low : | 4.25 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ BHC ] has closed below upper band by 18.7%. Bollinger Bands are 43.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 6.33 - 6.36 | 6.36 - 6.38 |
| Low: | 5.83 - 5.86 | 5.86 - 5.89 |
| Close: | 6.08 - 6.13 | 6.13 - 6.18 |
Sat, 21 Feb 2026
(BHC) Strategic Investment Guide (BHC:CA) - Stock Traders Daily
Fri, 20 Feb 2026
Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now? - TradingView
Fri, 20 Feb 2026
BHC offers free six‑week Court Reporting Basic Training - Kewanee Voice
Thu, 19 Feb 2026
Bausch Health Cos (NYSE:BHC) Shares Gap Down - Time to Sell? - MarketBeat
Thu, 19 Feb 2026
BHC Stock Down on Q4 Earnings Miss, Salix Drives Revenue Growth - Zacks Investment Research
Thu, 19 Feb 2026
How Bausch Health’s Turnaround Progressed In Q4 2025 (NYSE:BHC) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 371 (M) |
| Shares Float | 223 (M) |
| Held by Insiders | 10.6 (%) |
| Held by Institutions | 64.5 (%) |
| Shares Short | 5,030 (K) |
| Shares Short P.Month | 6,410 (K) |
| EPS | 1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -1.52 |
| Profit Margin | 3.6 % |
| Operating Margin | 26.7 % |
| Return on Assets (ttm) | 4.8 % |
| Return on Equity (ttm) | 563.1 % |
| Qtrly Rev. Growth | 6.8 % |
| Gross Profit (p.s.) | 19.13 |
| Sales Per Share | 27.07 |
| EBITDA (p.s.) | 8.87 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 1,510 (M) |
| Levered Free Cash Flow | 1,240 (M) |
| PE Ratio | 6.13 |
| PEG Ratio | 0 |
| Price to Book value | -4.04 |
| Price to Sales | 0.22 |
| Price to Cash Flow | 1.5 |
| Dividend | 1 |
| Forward Dividend | 0 |
| Dividend Yield | 16.3% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|